Page 1 | Search Results | Blood | American Society of Hematology

1-19 of 19

Sort by

Sort Order Select

Journal Articles

Baseline Characteristics from CLL-ZANU2024, an Italian Non-Interventional Study Assessing the Real-World Use of Zanubrutinib in the Treatment of Patients with Chronic Lymphocytic Leukemia (CLL)

Enrica Antonia Martino, Raffaella Pasquale, Isacco Ferrarini, Riccardo Moia, Andrea Visentin, Alessandro Sanna, Marina Motta, Massimo Moratti, Paolo Sportoletti, Annalisa Chiarenza, Alessandro Maggi, Valentina Zammit, Michele Merli, Idanna Innocenti, Claudia Giordano, Laura Nocilli, Massimiliano Postorino, Caterina Stelitano, Andrea Ferrario, Annamaria Frustaci, Stefania Scardino, Paola Anticoli Borza, Laura Ballotta, Salvatrice Mancuso, Gerardo Musuraca, Anna Mele, Sara Galimberti, Gioacchino Catania, Annamaria Giordano, Ilaria Angeletti, Luana Schiattone, Elsa Pennese, Rosanna Miccolis, Angelo Fama, Giulio Giordano, Catello Califano, Ernesto Vigna, Antonella Bruzzese, Giuliana Farina, Pietro Bulian, Giacomo Loseto, Barbara Pocali, Vanessa Innao, Piero Galieni, Vincenzo Ludovico Fraticelli, Candida Vitale, Azzurra Anna Romeo, Marco Rossi, Ilaria Scortechini, Federico Vozzella, Luigi Malandruccolo, Enrico Derenzini, Valentina di Martina, Roberto Marasca, Maria Ilaria Del Principe, Marta Coscia, Nicola Di Renzo, Luca Laurenti, Antonino Neri, Pellegrino Musto, Francesco Di Raimondo, Alessandra Tedeschi, Livio Trentin, Gianluca Gaidano, Fortunato Morabito, Valter Gattei, Massimo Gentile

Blood (2024) 144 (Supplement 1): 6794.

https://doi.org/10.1182/blood-2024-205354

Published: 2024

Journal Articles

Outcomes of Venetoclax Retreatment after MRD-Guided Venetoclax +/- Ibrutinib: Results of the Improve Study

Blood (2023) 142 (Supplement 1): 6521.

https://doi.org/10.1182/blood-2023-174603

Published: 2023

Journal Articles

Efficacy and Safety of Ibrutinib in Relapsed or Refractory Marginal Zone Lymphomas: The “Real World” Italian Experience

Blood (2023) 142 (Supplement 1): 1680.

https://doi.org/10.1182/blood-2023-182347

Published: 2023

Journal Articles

Minimal residual disease–driven treatment intensification with sequential addition of ibrutinib to venetoclax in R/R CLL

Blood (2022) 140 (22): 2348–2357.

https://doi.org/10.1182/blood.2022016901

Published: 2022

Includes: Supplemental data

Journal Articles

An Observational Study on Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Treated with Venetoclax-Based Regimens Outside Clinical Trials in Italy (GIMEMA CLL1920)

Blood (2021) 138 (Supplement 1): 3746.

https://doi.org/10.1182/blood-2021-148696

Published: 2021

Journal Articles

Minimal Residual Disease-Driven Treatment Intensification By Sequential Addition of Ibrutinib to Venetoclax in Relapsed/Refractory Chronic Lymphocytic Leukemia: Results of the Monotherapy and Combination Phases of the Improve Study

Blood (2020) 136 (Supplement 1): 21–22.

https://doi.org/10.1182/blood-2020-136507

Published: 2020

Journal Articles

Clonal B-Cell Lymphocytosis with Mariginal-Zone Features: Comparison with Overt Splenic Marginal-Zone Lymphomas in 77 Patients from a Monocentric Series

Michele Merli, MD, Benedetta Bianchi, MD, Lorenza Bertù, Andrea Ferrario, MD, Barbara Mora, Silvia Uccella, MD, Daniela Furlan, Maria Grazia Tibiletti, Simona Cattaneo, Fausto Sessa, Prof., Francesco Passamonti, Prof.

Blood (2019) 134 (Supplement_1): 4017.

https://doi.org/10.1182/blood-2019-130288

Published: 2019

Journal Articles

Pre-Treatment with Bendamustine Does Not Affect Stem Cell Mobilization in Patients with Indolent Non-Hodgkin Lymphomas: A Multicenter Study on Behalf of the Fondazione Italiana Linfomi

Michele Merli, MD, Stefano Luminari, MD, Lucia Farina, Federica Cocito, MD, Irene Defrancesco, MD, Guido Gini, MD, Annalisa Arcari, MD, Greta Scapinello, MD, Massimo Gentile, MD, Maria Goldaniga, MD, Giacomo Loseto, MD, Emanuele Cencini, MD, Antonino Greco, MD, Andrea Ferrario, MD, Benedetta Bianchi, MD, Francesca Gaia Rossi, MD, Silvia Bolis, MD, Francesco Passamonti, MD, Luca Arcaini, MD

Blood (2018) 132 (Supplement 1): 2066.

https://doi.org/10.1182/blood-2018-99-113536

Published: 2018

Journal Articles

Allogeneic Stem Cell Transplantation Versus B-Cell-Receptor Inhibitors in 17p Deletion and/or Refractory Chronic Lymphocytic Leukemia: A Retrospective Comparative Analysis of 'Real Life' Approaches to High Risk Patients, on Behalf of Rete Ematologica Lombarda (REL) and Gruppo Italiano Trapianto Di Midollo Osseo (GITMO)

Lucia Farina, MD PhD, Francesca Patriarca, Maddalena Mazzucchelli, Chiara Salvetti, MD, Giulia Quaresmini, Marta Medeot, MD, Daniele Vincenti, Gianluigi Reda, MD, Andrea Ferrario, MD, Francesco Zallio, MD, Anna Dodero, Benedetto Bruno, MD PhD, Paolo Corradini, Marco Montillo, MD

Blood (2016) 128 (22): 4695.

https://doi.org/10.1182/blood.V128.22.4695.4695

Published: 2016

Journal Articles

Secondary Acute Myeloid Leukemia Is an Heterogeneous Subgroup of Elderly AML Where Patient’s Fitness Criteria and ELN Prognostic Stratification Can be Applied to Guide Treatment Decisions: An Analysis of 127 Patients By the Network Rete Ematologica Lombarda (REL)

Erika Borlenghi, MD, Chiara Pagani, MD, Claudia Basilico, MD, Massimo Bernardi, MD, Matteo Carrabba, MD, Nicola Fracchiolla, MD, Francesca Guidotti, MD, Laura Marbello, MD, Andrea Ferrario, MD, Silvia Ferrari, MD, Francesca Schieppati, MD, Daniela Dalceggio, MD, Giuseppe Rossi, MD

Blood (2014) 124 (21): 953.

https://doi.org/10.1182/blood.V124.21.953.953

Published: 2014

Journal Articles

Antibiotic Prophylaxis Revisited: The Impact of Fluoroquinolones on Epidemiology and on the Emergence of Resistant Strains in Acute Leukemia Patients. Results of a Prospective Study By the Rete Ematologia Lombarda (REL)

Chiara Cattaneo, MD, Patrizia Zappasodi, MD, Silvia Ferrari, MD, Francesca Pavesi, MD, Claudio Annaloro, MD, Cristina Skert, MD, Luisa Verga, MD, Elisabetta Todisco, MD, Andrea Ferrario, MD, Vittoria Saccà, Angela Passi, MD, Erika Borlenghi, MD, Matteo C Da Vià, MD, Valentina Mancini, Gabriella Mometto, Claudia Basilico, MD, Roberto Cairoli, Annamaria Nosari, Giuseppe Rossi, MD

Blood (2014) 124 (21): 4125.

https://doi.org/10.1182/blood.V124.21.4125.4125

Published: 2014

Journal Articles

Validating the Patient's "Fitness" Criteria Proposed to Guide Treatment Decision in Elderly AML: a Multicenter Study on a Population-Based Series of 362 Patients By the Network "Rete Ematologica Lombarda" (REL)

Erika Borlenghi, MD, Chiara Pagani, MD, Claudia Basilico, MD, Massimo Bernardi, MD, Nicola Fracchiolla, MD, Francesca Guidotti, MD, Laura Marbello, MD, Andrea Ferrario, MD, Carlo Messina, MD, Emanuele Ravano, MD, Cinzia Lamorgese, Marta Petullà, Giuseppe Rossi, MD

Blood (2014) 124 (21): 279.

https://doi.org/10.1182/blood.V124.21.279.279

Published: 2014

Journal Articles

A Retrospective Analysis of Mantle Cell Lymphoma Patients Series Treated Upfront by Sequential High Dose Immunochemotherapy Supported by In Vivo Purged Stem Celle Double Autologous Transplantation: A Monocentric Experience

Andrea Ferrario, MD, Giorgia Saporiti, MD, Nicola Orofino, MD, Francesco Onida, MD, Daniele Vincenti, MD, Claudia Basilico, MD, Francesca Gaia Rossi, MD, Barbara Olivero, MD, Maria Cecilia Goldaniga, MD, Elena Tagliaferri, MD, Claudio Annaloro, MD, Luca Baldini, Prof

Blood (2011) 118 (21): 4949.

https://doi.org/10.1182/blood.V118.21.4949.4949

Published: 2011

Journal Articles

Prognostic Models to Predict Survival In Indolent and Aggressive Non-Hodgkin's Lymphomas Associated with Hepatitis C Virus Infection: a Multicenter Italian Study on 1,043 Patients.

Michele Merli, MD, Michele Spina, MD, Stefano Luminari, MD, Claudia Basilico, MD, Clara Targhetta, MD, Carlo Visco, MD, Alessandro Levis, MD, Davide Rossi, MD, Alfonso Maria D'Arco, MD, Luigi Rigacci, MD, Achille Ambrosetti, MD, Pellegrino Musto, MD, Alessandra Tucci, MD, Annalisa Chiappella, MD, Andrea Ferrario, MD, Sara Rattotti, MD, Virginia Valeria Ferretti, PhD, Cristiana Pascutto, PhD, Luca Arcaini, MD

Blood (2010) 116 (21): 2821.

https://doi.org/10.1182/blood.V116.21.2821.2821

Published: 2010

Journal Articles

Indolent B-Cell Lymphomas Treated Upfront with Antiviral Therapy: a Series of 13 Patients

Andrea Ferrario, MD, Alessio Aghemo, MD, Maria Cecilia Goldaniga, MD, Michele Merli, MD, Daniele Vincenti, MD, Francesca Gaia Rossi, MD, Elisabetta De Gasperi, MD, Barbara Olivero, MD, Lilla Cro, PhD, Sara Rattotti, MD, Luca Arcaini, MD, Francesco Onida, MD, Luca Baldini, Prof

Blood (2010) 116 (21): 2876.

https://doi.org/10.1182/blood.V116.21.2876.2876

Published: 2010

Journal Articles

Clinical-Biological Characterization of Variant B Chronic Lymphocytic Leukemia, Characterized by a Mantle Cell Lymphoma-Like Immunophenotype, t(11;14)(q13;q32) Negative.

Andrea Ferrario, MD, Lilla Cro, PhD, Nadia Zucal, Marta Lionetti, PhD, Francesco Bertoni, MD, Lucia Nobili, PhD, Sonia Fabris, PhD, Katia Todoerti, PhD, Fortunato Morabito, MD, Giovanna Cutrona, PhD, Agostino Cortelezzi, MD, Andrea Guffanti, MD, Maria Cecilia Goldaniga, MD, Stefano Luminari, MD, Luigi Marcheselli, PhD, Manlio Ferrarini, MD, Antonino Neri, MD, Giorgio Lambertenghi Deliliers, MD, Luca Baldini, MD

Blood (2009) 114 (22): 1259.

https://doi.org/10.1182/blood.V114.22.1259.1259

Published: 2009

Journal Articles

Front-Line Chemo-Immunotherapy Rituximab-FC + Rituximab Maintenance in Patients with Untreated Advanced Stage Non Follicular Lymphoma (INFL): Update of a Prospective Study of the Intergruppo Italiano Linfomi and Roche (ML18324).

Luca Baldini, MD, Alessandro Pulsoni, MD, Giuseppe Rossi, MD, Umberto Vitolo, Enrica Morra, MD, Barbara Olivero, MD, Elena Cavalieri, MD, Francesco Merli, MD, Luigi Rigacci, Francesco Nobile, MD, Andrea Ferrario, MD, Lorella Orsucci, MD, Maura Brugiatelli, MD, Pellegrino Musto, MD, Giorgio Lambertenghi Deliliers, MD, Enrica Gamba, MD

Blood (2009) 114 (22): 2686.

https://doi.org/10.1182/blood.V114.22.2686.2686

Published: 2009

Journal Articles

Diagnostic Role of Flow Cytometry Analysis of Bioptical Samples in the Diagnosis of Lymphoid Tumors

Lilla Cro, PhD, Andrea Ferrario, MD, Nadia Zucal, Umberto Gianelli, MD, Sonia Fabris, PhD, Lucia Nobili, PhD, Barbara Olivero, MD, Francesca G Rossi, MD, Luca Baldini, MD, Giorgio Lambertenghi Deliliers, MD

Blood (2008) 112 (11): 5286.

https://doi.org/10.1182/blood.V112.11.5286.5286

Published: 2008

Journal Articles

The Cytofluorimetric/FISH Diagnostic Approach Define a B-Cell Variant-CLL with Peculiar Clinico-Biological Features.

Lilla Cro, Luca Baldini, Lucia Nobili, Antonino Neri, Nadia Zucal, Andrea Ferrario, Marta Lionetti, Francesco Bertoni, Fortunato Morabito, Andrea Guffanti, Maria Goldaniga, Giovanna Cutrona, Agostino Cortelezzi, Stefano Luminari8, Manlio Ferrarini, Giorgio Lambertenghi Deliliers

Blood (2007) 110 (11): 2077.

https://doi.org/10.1182/blood.V110.11.2077.2077

Published: 2007

NARROW

Baseline Characteristics from CLL-ZANU2024, an Italian Non-Interventional Study Assessing the Real-World Use of Zanubrutinib in the Treatment of Patients with Chronic Lymphocytic Leukemia (CLL)

Outcomes of Venetoclax Retreatment after MRD-Guided Venetoclax +/- Ibrutinib: Results of the Improve Study

Efficacy and Safety of Ibrutinib in Relapsed or Refractory Marginal Zone Lymphomas: The “Real World” Italian Experience

Minimal residual disease–driven treatment intensification with sequential addition of ibrutinib to venetoclax in R/R CLL

An Observational Study on Patients with Relapsed/Refractory Chronic Lymphocytic Leukemia Treated with Venetoclax-Based Regimens Outside Clinical Trials in Italy (GIMEMA CLL1920)

Minimal Residual Disease-Driven Treatment Intensification By Sequential Addition of Ibrutinib to Venetoclax in Relapsed/Refractory Chronic Lymphocytic Leukemia: Results of the Monotherapy and Combination Phases of the Improve Study

Clonal B-Cell Lymphocytosis with Mariginal-Zone Features: Comparison with Overt Splenic Marginal-Zone Lymphomas in 77 Patients from a Monocentric Series

Pre-Treatment with Bendamustine Does Not Affect Stem Cell Mobilization in Patients with Indolent Non-Hodgkin Lymphomas: A Multicenter Study on Behalf of the Fondazione Italiana Linfomi

Secondary Acute Myeloid Leukemia Is an Heterogeneous Subgroup of Elderly AML Where Patient’s Fitness Criteria and ELN Prognostic Stratification Can be Applied to Guide Treatment Decisions: An Analysis of 127 Patients By the Network Rete Ematologica Lombarda (REL)

Antibiotic Prophylaxis Revisited: The Impact of Fluoroquinolones on Epidemiology and on the Emergence of Resistant Strains in Acute Leukemia Patients. Results of a Prospective Study By the Rete Ematologia Lombarda (REL)

Validating the Patient's "Fitness" Criteria Proposed to Guide Treatment Decision in Elderly AML: a Multicenter Study on a Population-Based Series of 362 Patients By the Network "Rete Ematologica Lombarda" (REL)

A Retrospective Analysis of Mantle Cell Lymphoma Patients Series Treated Upfront by Sequential High Dose Immunochemotherapy Supported by In Vivo Purged Stem Celle Double Autologous Transplantation: A Monocentric Experience

Prognostic Models to Predict Survival In Indolent and Aggressive Non-Hodgkin's Lymphomas Associated with Hepatitis C Virus Infection: a Multicenter Italian Study on 1,043 Patients.

Indolent B-Cell Lymphomas Treated Upfront with Antiviral Therapy: a Series of 13 Patients

Clinical-Biological Characterization of Variant B Chronic Lymphocytic Leukemia, Characterized by a Mantle Cell Lymphoma-Like Immunophenotype, t(11;14)(q13;q32) Negative.

Front-Line Chemo-Immunotherapy Rituximab-FC + Rituximab Maintenance in Patients with Untreated Advanced Stage Non Follicular Lymphoma (INFL): Update of a Prospective Study of the Intergruppo Italiano Linfomi and Roche (ML18324).

Diagnostic Role of Flow Cytometry Analysis of Bioptical Samples in the Diagnosis of Lymphoid Tumors

The Cytofluorimetric/FISH Diagnostic Approach Define a B-Cell Variant-CLL with Peculiar Clinico-Biological Features.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only